Stocks Overview

LAST PRICE
42.6300
TODAY'S CHANGE (%)
Trending Down-0.0800 (-0.1873%)

Bid / Lots
42.5900/ 3
Ask / Lots
42.7500/ 1
Open / Previous Close
42.7300 / 42.7100
Day Range
Low 42.6000
High 42.8600
52 Week Range
Low 19.5900
High 43.5898
Volume
1,152,986
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 42.71
Time	Volume	CERE
09:32 ET	2555	42.77
09:34 ET	2033	42.84
09:36 ET	200	42.81
09:38 ET	2300	42.82
09:39 ET	900	42.82
09:41 ET	3180	42.76
09:43 ET	3316	42.79
09:45 ET	400	42.8
09:48 ET	500	42.78
09:50 ET	533	42.79
09:52 ET	2400	42.81
09:54 ET	800	42.805
09:56 ET	720	42.785
09:57 ET	400	42.765
09:59 ET	200	42.77
10:01 ET	1400	42.76
10:03 ET	1394	42.73
10:06 ET	1056	42.725
10:08 ET	355	42.725
10:10 ET	300	42.72
10:12 ET	753	42.68
10:14 ET	939	42.7
10:15 ET	1820	42.7
10:17 ET	600	42.71
10:19 ET	1100	42.71
10:21 ET	100	42.71
10:24 ET	200	42.735
10:26 ET	100	42.74
10:28 ET	200	42.745
10:30 ET	627	42.77
10:32 ET	692	42.775
10:33 ET	500	42.8
10:35 ET	1276	42.8
10:37 ET	3834	42.74
10:39 ET	400	42.775
10:42 ET	4861	42.71
10:44 ET	2298	42.715
10:46 ET	600	42.715
10:48 ET	3160	42.685
10:50 ET	6403	42.715
10:51 ET	1400	42.695
10:53 ET	10011	42.705
10:55 ET	1845	42.685
10:57 ET	1685	42.705
11:00 ET	2137	42.685
11:02 ET	1126	42.69
11:04 ET	560	42.715
11:06 ET	1033	42.705
11:08 ET	2068	42.705
11:09 ET	496	42.705
11:11 ET	1689	42.695
11:13 ET	733	42.69
11:15 ET	3538	42.7
11:18 ET	2548	42.67
11:20 ET	800	42.685
11:22 ET	700	42.685
11:24 ET	100	42.685
11:26 ET	914	42.69
11:27 ET	672	42.68
11:29 ET	1634	42.635
11:31 ET	614	42.625
11:33 ET	747	42.61
11:36 ET	858	42.62
11:38 ET	1300	42.63
11:40 ET	2004	42.64
11:42 ET	700	42.63
11:44 ET	833	42.63
11:45 ET	100	42.635
11:47 ET	1114	42.625
11:49 ET	686	42.64
11:51 ET	200	42.645
11:54 ET	100	42.645
11:56 ET	100	42.64
11:58 ET	1142	42.635
12:00 ET	200	42.63
12:02 ET	2665	42.62
12:03 ET	100	42.615
12:05 ET	700	42.645
12:07 ET	100	42.645
12:09 ET	3169	42.62
12:12 ET	200	42.635
12:14 ET	300	42.635
12:16 ET	300	42.635
12:18 ET	1100	42.63
12:20 ET	300	42.635
12:21 ET	833	42.645
12:23 ET	2529	42.625
12:25 ET	690	42.62
12:27 ET	508	42.625
12:30 ET	784	42.615
12:32 ET	2498	42.605
12:34 ET	1200	42.63
12:36 ET	300	42.64
12:38 ET	500	42.655
12:39 ET	400	42.655
12:41 ET	500	42.655
12:43 ET	1130	42.635
12:45 ET	1100	42.63
12:48 ET	300	42.61
12:50 ET	2046	42.62
12:52 ET	700	42.625
12:54 ET	300	42.62
12:56 ET	300	42.625
12:57 ET	700	42.625
12:59 ET	600	42.625
01:01 ET	200	42.625
01:03 ET	800	42.62
01:06 ET	1500	42.625
01:08 ET	800	42.63
01:10 ET	3244	42.63
01:12 ET	100	42.625
01:14 ET	400	42.625
01:15 ET	600	42.625
01:17 ET	400	42.625
01:19 ET	2790	42.6652
01:21 ET	2208	42.68
01:24 ET	1670	42.67
01:26 ET	100	42.655
01:28 ET	1100	42.675
01:30 ET	708	42.67
01:32 ET	400	42.675
01:33 ET	361	42.675
01:35 ET	300	42.675
01:37 ET	2842	42.695
01:39 ET	1283	42.68
01:42 ET	700	42.685
01:44 ET	773	42.685
01:46 ET	22133	42.675
01:48 ET	10200	42.69
01:50 ET	2854	42.68
01:51 ET	2000	42.67
01:53 ET	100	42.665
01:55 ET	1238	42.67
01:57 ET	200	42.675
02:00 ET	528	42.67
02:02 ET	38285	42.69
02:04 ET	4380	42.71
02:06 ET	580	42.71
02:08 ET	2287	42.7
02:09 ET	2190	42.695
02:11 ET	4099	42.695
02:13 ET	759	42.695
02:15 ET	931	42.68
02:18 ET	200	42.685
02:20 ET	419	42.68
02:22 ET	800	42.685
02:24 ET	3273	42.7
02:26 ET	100	42.695
02:27 ET	1550	42.69
02:29 ET	400	42.7
02:31 ET	1304	42.69
02:33 ET	1588	42.69
02:36 ET	2439	42.68
02:38 ET	3225	42.7
02:40 ET	74877	42.8
02:42 ET	6119	42.79
02:44 ET	2875	42.74
02:45 ET	4239	42.75
02:47 ET	2424	42.78
02:49 ET	2717	42.72
02:51 ET	2300	42.7801
02:54 ET	3440	42.77
02:56 ET	3900	42.741
02:58 ET	2500	42.78
03:00 ET	1609	42.78
03:02 ET	3244	42.76
03:03 ET	5225	42.7
03:05 ET	937	42.67
03:07 ET	503	42.69
03:09 ET	1510	42.74
03:12 ET	645	42.735
03:14 ET	1583	42.73
03:16 ET	1002	42.7
03:18 ET	780	42.67
03:20 ET	1795	42.655
03:21 ET	1391	42.64
03:23 ET	2000	42.62
03:25 ET	3431	42.68
03:27 ET	1300	42.665
03:30 ET	1400	42.64
03:32 ET	1309	42.635
03:34 ET	2274	42.62
03:36 ET	3585	42.625
03:38 ET	1700	42.635
03:39 ET	28286	42.655
03:41 ET	4708	42.645
03:43 ET	7653	42.67
03:45 ET	1270	42.665
03:48 ET	8163	42.655
03:50 ET	7854	42.66
03:52 ET	9767	42.605
03:54 ET	10366	42.66
03:56 ET	16667	42.74
03:57 ET	7136	42.685
03:59 ET	13312	42.63

Data delayed at least 15 minutes.

Yesterday
- CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) Buyout and Encourages Investors to Contact the Firm, from 8:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
  8:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
Apr 18, 2024
- DJ AbbVie's Bet on a Neuroscience Drug Maker Just Got Better -- Heard on the Street -- WSJ, from 12:17PM ET on Thursday Apr 18, 2024 by Dow Jones
  12:17PM ET on Thursday Apr 18, 2024 by Dow Jones
- Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease, from 6:30AM ET on Thursday Apr 18, 2024 by Dow Jones
  6:30AM ET on Thursday Apr 18, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCERE Cerevel Therapeutics Holdings Inc	7.8B	-16.0x	---
United StatesVKTX Viking Therapeutics Inc	8.8B	-82.1x	---
United StatesPCVX Vaxcyte Inc	6.6B	-15.6x	---
United StatesCYTK Cytokinetics Inc	6.4B	-11.6x	---
United StatesRVMD Revolution Medicines Inc	6.4B	-10.3x	---
United StatesLEGN Legend Biotech Corp	8.0B	-14.9x	---
As of 2024-05-01

Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer’s disease psychosis, epilepsy, panic disorder and Parkinson’s disease. Its pipeline candidates include Emraclidine, Darigabat, Tavapadon and CVL-871. Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype (M4). Darigabat is a PAM that selectively targets the alpha 2/3/5 subunits of the GABAA receptor. Tavapadon is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of Parkinson’s disease.

Contact Information

Headquarters: 222 Jacobs Street, Suite 200CAMBRIDGE, MA, United States 02141
Phone: 212-284-2300
Fax: 302-636-5454

Executives

Chairperson of the Board of Directors: N. Coles
President, Chief Executive Officer, Member of the Board: Ronald Renaud
Chief Financial Officer: Susan Altschuller
Chief Human Resources Officer: Kenneth Dipietro
Senior Vice President - Finance, Chief Accounting Officer: Mark Bodenrader

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$7.8B
Revenue (TTM)	$0.00
Shares Outstanding	181.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.48
EPS	$-2.66
Book Value	$3.71
P/E Ratio	-16.0x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Cerevel Therapeutics Holdings Inc
NASDAQ:CEREUnited States

Search Criteria

Charts

Recent News

Yesterday

CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) Buyout and Encourages Investors to Contact the Firm, from 8:00AM ET on Tuesday Apr 30, 2024 by Dow Jones

Apr 18, 2024

DJ AbbVie's Bet on a Neuroscience Drug Maker Just Got Better -- Heard on the Street -- WSJ, from 12:17PM ET on Thursday Apr 18, 2024 by Dow Jones

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease, from 6:30AM ET on Thursday Apr 18, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar